188 related articles for article (PubMed ID: 15752773)
1. Growth kinetics of SARS-coronavirus in Vero E6 cells.
Keyaerts E; Vijgen L; Maes P; Neyts J; Van Ranst M
Biochem Biophys Res Commun; 2005 Apr; 329(3):1147-51. PubMed ID: 15752773
[TBL] [Abstract][Full Text] [Related]
2. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
[TBL] [Abstract][Full Text] [Related]
3. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.
Yamate M; Yamashita M; Goto T; Tsuji S; Li YG; Warachit J; Yunoki M; Ikuta K
Microbes Infect; 2005 Dec; 7(15):1530-40. PubMed ID: 16269264
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
5. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells.
Mizutani T; Fukushi S; Iizuka D; Inanami O; Kuwabara M; Takashima H; Yanagawa H; Saijo M; Kurane I; Morikawa S
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):236-43. PubMed ID: 16487305
[TBL] [Abstract][Full Text] [Related]
7. The life cycle of SARS coronavirus in Vero E6 cells.
Qinfen Z; Jinming C; Xiaojun H; Huanying Z; Jicheng H; Ling F; Kunpeng L; Jingqiang Z
J Med Virol; 2004 Jul; 73(3):332-7. PubMed ID: 15170625
[TBL] [Abstract][Full Text] [Related]
8. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle.
Li GM; Li YG; Yamate M; Li SM; Ikuta K
Microbes Infect; 2007 Jan; 9(1):96-102. PubMed ID: 17194611
[TBL] [Abstract][Full Text] [Related]
9. Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication.
Mossel EC; Huang C; Narayanan K; Makino S; Tesh RB; Peters CJ
J Virol; 2005 Mar; 79(6):3846-50. PubMed ID: 15731278
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.
Ni B; Shi X; Li Y; Gao W; Wang X; Wu Y
Antivir Ther; 2005; 10(4):527-33. PubMed ID: 16038478
[TBL] [Abstract][Full Text] [Related]
12. Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independent.
Leite G; Mehravar S; Pimentel M; Mathur R; Melmed GY; Teagle V; Barlow GM; Rezaie A
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104097. PubMed ID: 38677499
[TBL] [Abstract][Full Text] [Related]
13. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection.
Ng LF; Hibberd ML; Ooi EE; Tang KF; Neo SY; Tan J; Murthy KR; Vega VB; Chia JM; Liu ET; Ren EC
BMC Infect Dis; 2004 Sep; 4():34. PubMed ID: 15357874
[TBL] [Abstract][Full Text] [Related]
14. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
15. Proliferative growth of SARS coronavirus in Vero E6 cells.
Ng ML; Tan SH; See EE; Ooi EE; Ling AE
J Gen Virol; 2003 Dec; 84(Pt 12):3291-3303. PubMed ID: 14645910
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
Nyayanit DA; Sarkale P; Baradkar S; Patil S; Yadav PD; Shete-Aich A; Kalele K; Gawande P; Majumdar T; Jain R; Sapkal G
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):70-76. PubMed ID: 32773420
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M
Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384
[TBL] [Abstract][Full Text] [Related]
18. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM
Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951
[TBL] [Abstract][Full Text] [Related]
19. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
Li T; Zhang Y; Fu L; Yu C; Li X; Li Y; Zhang X; Rong Z; Wang Y; Ning H; Liang R; Chen W; Babiuk LA; Chang Z
Gene Ther; 2005 May; 12(9):751-61. PubMed ID: 15772689
[TBL] [Abstract][Full Text] [Related]
20. [Conditions for SARS-CoV cultivation and inactivation].
Zhang SL; Ma LJ; Tian G; Zhang LY; Zhang XY; Wang XL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):135-7. PubMed ID: 16027779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
